Based on the SCENIC algorithm and Chip-seq analysis, a STAT5-regulated, IL32-dependent ADGRE5 pathway was established and verified in our own independent NSCLC neo-PD1 cohorts. Here, STAT5B is linked to non-small cell lung carcinoma.